(Q38754506)

6 September 2017

title

Proconvulsant effects of antidepressants - What is the current evidence? (English)

1 reference

Cecilie Johannessen Landmark

6 September 2017

author

series ordinal

1

object named as

Cecilie Johannessen Landmark

1 reference

6 September 2017

3

Svein I Johannessen

1 reference

6 September 2017

Oliver Henning

2

1 reference

6 September 2017

publication date

23 February 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

61

1 reference

6 September 2017

page(s)

287-291

1 reference

The psychiatric comorbidity of epilepsy.

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

The association between depression and epilepsy in a nationally representative sample.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Psychiatric comorbidity in patients with epilepsy: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Depression and epilepsy, pain and psychogenic non-epileptic seizures: clinical and therapeutic perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Antiepileptic drugs in epilepsy and other disorders--a population-based study of prescriptions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Antiepileptic drug effects on mood and behavior: molecular targets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Use of psychotropic drugs in patients with epilepsy: interactions and seizure risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Psychiatric comorbidity and use of psychotropic drugs in epilepsy patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Depression in epilepsy: why aren't we treating?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Selecting an Antidepressant for Use in a Patient with Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Anticonvulsant effect of fluoxetine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Antidepressant overdose-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Chronic but not acute treatment with antidepressants enhances the electroconvulsive seizure response in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Assessment of the convulsant liability of antidepressants using zebrafish and mouse seizure models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

EEG in the FEAB model: measurement of electroencephalographical burst suppression and seizure liability in safety pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

The Use of Sertraline in Patients with Epilepsy: Is It Safe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Safety of antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

The clinical role of genetic polymorphisms in drug-metabolizing enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Epilepsy, suicidality, and psychiatric disorders: a bidirectional association.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

The treatment of depressive disorders in epilepsy: what all neurologists should know

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Suicidal antidepressant overdoses: a comparative analysis by antidepressant type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Amoxapine overdose. Seizures and fatalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Seizures associated with high maprotiline serum concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Maprotiline treatment in depression. A perspective on seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Incidence of seizures with tricyclic and tetracyclic antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Relative toxicity of cyclic antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Pharmacogenomics and individualized drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64 years: cohort study using a primary care database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Methodologies used to identify and characterize interactions among antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Anticonvulsants - antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Antiepileptic drug interactions - principles and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Drug interactions involving the new second- and third-generation antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Therapeutic drug monitoring of psychotropic drugs. TDM "nouveau".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Host factors affecting antiepileptic drug delivery-pharmacokinetic variability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Serum concentrations of antidepressants in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Value of therapeutic drug monitoring in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

Safety aspects of antiepileptic drugs--focus on pharmacovigilance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2016.01.029

10.1016/J.YEBEH.2016.01.029

7 January 2021

Identifiers

DOI

1 reference

6 September 2017

1 reference